In summary, our results highlight the potential of the NHC-Gold complexes Au3BC and Au4BC in the treatment of HCC and BC, and demonstrated that the two complexes showed different mechanisms of action, either dependent or independent on TrxR1 inhibition. This evidence concerns the gene TXNRD1 and breast cancer.